e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
New mechanisms in chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vascular remodelling in pulmonary hypertension: A role for matrix cross-linking?
A. Nave, N. Kneidinger, G. Kwapiszewska, W. Seeger, R. Morty (Giessen, Germany)
Source:
Annual Congress 2010 - New mechanisms in chronic lung diseases
Session:
New mechanisms in chronic lung diseases
Session type:
Oral Presentation
Number:
5544
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Nave, N. Kneidinger, G. Kwapiszewska, W. Seeger, R. Morty (Giessen, Germany). Vascular remodelling in pulmonary hypertension: A role for matrix cross-linking?. Eur Respir J 2010; 36: Suppl. 54, 5544
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Vascular wall remodeling in patients with chronic thromboembolic pulmonary hypertension: a role for C-reactive protein
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008
Olfactory receptors in pulmonary arterial hypertension: A novel pathway of vascular remodeling?
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Dual mechanism of platelet-derived growth factor (PDGF)-receptor: Contribution of vascular response to the pathogenesis of pulmonary hypertension (PH)
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Pulmonary hypertension: the science behind the disease spectrum
Source: Eur Respir Rev 2012; 21: 19-26
Year: 2012
Late Breaking Abstract - NGF induces pulmonary arterial hyperreactivity through increased connexin-43 expression: potential role in pulmonary hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018
Pulmonary vascular remodelling in pulmonary disease
Source: Annual Congress 2011 - The burden of pulmonary hypertension in respiratory disease
Year: 2011
LATE-BREAKING ABSTRACT: TNFalpha mediates ectodomain shedding of BMPR-II: A potential role in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
LATE-BREAKING ABSTRACT: Evidence for a critical contribution of pericytes in pulmonary arterial hypertension pathogenesis
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Deciphering the "matrix" in pulmonary vascular remodelling
Source: Eur Respir J 2005; 25: 778-779
Year: 2005
Pathobiology of pulmonary arterial hypertension
Source: Eur Respir J 2002; 20: 1559-1572
Year: 2002
Molecular determinants of cardiac and pulmonary vascular remodeling in scleroderma-related pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases
Year: 2008
Bone morphogenetic protein receptor-II as a regulator of pulmonary artery endothelial cell permeability: Relevance to the initiation and progression of heritable pulmonary arterial hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
mir-126 contribute to angiogenesis defect in pulmonary arterial hypertension right ventricle failure
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Arterial remodelling in patients with idiopathic pulmonary fibrosis (IPF) and the possible role of endothelial to mesenchymal transition (EndMT)
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
Vascular remodeling in chronic thromboembolic pulmonary hypertension: Involvement of dedifferentiated smooth muscle cells and C-reactive protein
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Smooth muscle microparticles as novel biomarkers of vascular remodelling and inflammation in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Potential contribution of precursor cells to vascular remodeling in the AdTGF-β1 model of lung fibrosis and pulmonary hypertension
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
Analysis of pulmonary endothelial microparticles, haemodynamics and functional class in pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Involvement of FHL1 in vascular remodelling
Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept